Join to View Full Profile
925 Chestnut StSte 320APhiladelphia, PA 19107
Phone+1 215-955-1175
Fax+1 215-955-2340
Dr. Orloff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2012 - 2015- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2009 - 2012
Pennsylvania State University College of MedicineClass of 2009
Certifications & Licensure
PA State Medical License 2009 - 2026
DE State Medical License 2017 - 2025
NJ State Medical License 2017 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver Start of enrollment: 2018 May 02
- A Prospective Natural History Study in Uveal Melanoma Start of enrollment: 2021 May 06
- Study of IDE196 in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions Start of enrollment: 2019 Jun 28
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsTebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of Action.Jessica C Hassel, Sarah Stanhope, Alexander Greenshields-Watson, Devayani Machiraju, Alexander Enk
The Journal of Investigative Dermatology. 2025-03-01 - Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.Florentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, Phil F Cheng, Isaac F Hughes
European Journal of Cancer. 2025-01-01 - Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.Rino S Seedor, Andrew E Aplin, Corine Bertolotto, Richard D Carvajal, Nigel Deacon
Pigment Cell & Melanoma Research. 2025-01-01
Press Mentions
TriSalus Life Sciences Expands Clinical Executive Team and Scientific Advisors in Support of Company’s Focus to Overcome Liver and Pancreatic Cancer Treatment Barriers and Enable More Patients to Benefit from ImmunotherapyFebruary 10th, 2022- Metastatic Uveal Melanoma: New Drugs in Pipeline, but Prognoses Remain GrimDecember 14th, 2021
- TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver MetastasesSeptember 7th, 2021
- Join now to see all
External Links
- Jefferson Linkhttp://hospitals.jefferson.edu/find-a-doctor/o/orloff-marlana-m/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
